March 31 2025- Following an extensive national search, NYU Langone Health has named Alec C. Kimmelman, MD, PhD, as its next chief executive officer and dean of NYU Grossman School of Medicine. Dr. Kimmelman, a distinguished physician and internationally renowned researcher, most recently served as director of the Laura and Isaac Perlmutter Cancer Center at NYU Langone since 2023 and has been a leader at the institution since 2016.

His appointment, which takes effect September 1, follows the retirement of Robert I. Grossman, MD, who in his 18 years transformed NYU Langone Health from what was once a small regional hospital into one of the nation’s premier integrated academic health systems with 7 inpatient locations, over 320 outpatient sites, two tuition-free medical schools, and a vast research enterprise. Dr. Kimmelman’s appointment was confirmed in a unanimous vote by NYU Langone’s Board of Trustees.

“We are excited to name Dr. Kimmelman to this position given his extraordinary talent, leadership experience, and strong character. He is the right choice to build on Bob’s legacy and lead our institution into its next phase of innovation and impact,” said Kenneth Langone, chair of the NYU Langone Board of Trustees, and co-chair of the search committee. “Finding Bob’s successor was a formidable task, given his countless contributions to our institution, but we found such a leader in Dr. Kimmelman, who has demonstrated tremendous leadership throughout his career.” 

“I am humbled and excited to be the next CEO and dean of NYU Langone and appreciate the confidence the Board of Trustees and the search committee have placed in me. I look forward to building upon Dr. Grossman’s astonishing record of achievements that have catapulted this institution to be one of the top-ranked health systems in the nation,” said Dr. Kimmelman. “This is a wonderful opportunity to lead and support our talented and dedicated team as we work together to deliver the best outcomes in patient care, education, and science.” 

“Throughout his career at NYU Langone, most recently leading Perlmutter Cancer Center, Dr. Kimmelman has further established our integrated academic health system as a leader in research and treatment, particularly through his innovative work in molecular oncology,” Dr. Grossman said. “Leading NYU Langone for the past 18 years has been the honor of a lifetime, and I could not ask for a better successor. His wealth of expertise and sharp leadership skills will serve NYU Langone exceedingly well as we continue to advance our mission: to care, to teach, to discover, and to provide the best patient experience across all our disciplines and network.”

“I am thrilled to begin my tenure later this year as chair of NYU Langone’s Board of Trustees as Dr. Kimmelman begins his tenure as CEO and dean,” said Fiona B. Druckenmiller. “Ken and Dr. Grossman shared a bold vision and an amazing partnership that made NYU Langone what it is today. I am excited to cultivate a similar working relationship with Dr. Kimmelman as we forge ahead together to bring the highest quality care to our patients and communities.”

“Eighteen years ago, I had the privilege of chairing the search committee that appointed Dr. Grossman, and I have taken great pride in that decision ever since. Today, after looking back on all that NYU Langone has achieved under his leadership, I now look forward to all that we can accomplish under Dr. Kimmelman,” said Department of Orthopedic Surgery Chair Joseph D. Zuckerman, MD, search committee co-chair. “This is the right choice at the right time to sustain the incredible momentum that will drive NYU Langone into the future.”

Also Read : MD Anderson Cancer Center names Jeffrey E. Lee as Chief Medical Executive

“Over the past two decades, the entire New York University community has watched with admiration NYU Langone’s ascent to one of the nation’s top academic health systems under Dr. Grossman’s leadership,” said NYU President Linda G. Mills. “After hearing Dr. Kimmelman’s vision for the future of NYU Langone, through my role on the search committee, the choice was clear: He is far and away the best person to lead this truly exceptional health system into its next era.”